We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

74 hedge funds and large institutions have $1.16B invested in Olema Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 16

30% more funds holding

Funds holding: 57 → 74 (+17)

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

3.32% less ownership

Funds ownership: 91.05% → 87.73% (-3.3%)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

30% less capital invested

Capital invested by funds: $1.66B → $1.16B (-$499M)

Holders
74
Holders Change
+17
Holders Change %
+29.82%
% of All Funds
1.3%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
33
Increased
15
Reduced
13
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$32.9M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$8.04M
3
State Street
State Street
Massachusetts
+$7.45M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.25M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.99M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$18.2M
2
FCMI
Foresite Capital Management IV
California
-$18.2M
3
APM
Avidity Partners Management
Texas
-$13M
4
Invesco
Invesco
Georgia
-$12.2M
5
DCM
Driehaus Capital Management
Illinois
-$4.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
76
Marshall Wace North America
New York
– -$1.14M -23,793 Closed
HF
77
HRT Financial
New York
– -$1.1M -22,991 Closed
ECM
78
ExodusPoint Capital Management
New York
– -$1.04M -21,629 Closed
Millennium Management
79
Millennium Management
New York
– -$892K -18,553 Closed
PCM
80
Pinz Capital Management
New York
– -$856K -17,800 Closed
SFM
81
Sphera Funds Management
Israel
– -$731K -15,200 Closed
JG
82
Jefferies Group
New York
– -$726K -15,100 Closed
SG Americas Securities
83
SG Americas Securities
New York
– -$591K -12,300 Closed
TEE
84
Tibra Equities Europe
United Kingdom
– -$591K -12,300 Closed
MFS
85
Mirabella Financial Services
United Kingdom
– -$505K -10,500 Closed
Qube Research & Technologies (QRT)
86
Qube Research & Technologies (QRT)
United Kingdom
– -$427K -8,882 Closed
WCA
87
Windsor Creek Advisors
Vermont
– -$288K -6,000 Closed
M&T Bank
88
M&T Bank
New York
– -$254K -5,283 Closed
KC
89
Kinloch Capital
Virginia
– -$24K -500 Closed
CS
90
Candriam SCA
Luxembourg
– +$557 +13 New
1 2 3
4

OLMA Hedge Fund Activity: Q1 2021 in Review

74 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2021, worth a combined $1.16B — down 30% from $1.66B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new OLMA positions and 16 closed out — a net gain of 17 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $32.9M. The largest seller was Deerfield Management, cutting an estimated $18.2M.

  • 74 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2021, up from 57 in Q4 2020.
  • Funds reported $1.16B of Olema Pharmaceuticals stock for Q1 2021, down 30% quarter-over-quarter.
  • 33 funds opened new Olema Pharmaceuticals positions in Q1 2021 and 16 closed out, a net change of +17 holders.
  • The largest Olema Pharmaceuticals buyer in Q1 2021 was BlackRock, an estimated $32.9M added.
  • The largest Olema Pharmaceuticals seller in Q1 2021 was Deerfield Management, an estimated $18.2M sold.

Based on aggregated 13F filings for Q1 2021.